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SUMMARY 
The tissue distribution kinetics and elimination of 4,4’-methylene bis(2-chloroaniline) (MBOCA) in 
rats was studied after a single dose of [%Z]MBOCA (0.49 mg/kg body weight, iv.). The highest concen- 
trations of radioactivity were in the small intestine, liver, adipose, lung, kidney, skin, and adrenals. For 
most tissues, a rapid decrease in radioactivity was followed by a slower decrease except for the small in- 
testine, adipose and skin which demonstrated transient increases. Subcellular distribution in liver at 1 h 
showed radioactivity in all cell fractions. Although very lipophilic, [%]MBOCA was completely 
eliminated within 48 h with the major route via the feces (73.4%). 
INTRODUCTION 
MBOCA, also known as MOCA and Curene 442, is a curing agent used in 
polyurethane plastics. The mutagenicity of MBOCA was demonstrated in the Ames’ 
Salmonella/microsome test [ 1, 21. The carcinogenicity of MBOCA was 
demonstrated in mice [3], rats [3-51, and dogs [6]. After prolonged exposure to 
MBOCA, the predominant neoplasms were located in lung, liver and bladder [3-61, 
however, neoplasms were also found in other tissues [3-51. 
Very limited information is available on the body burden of MBOCA, its distribu- 
tion, and its relationship to the sites of observed neoplasms. Since MBOCA is a 
lipophilic compound with an octanol/water partition coefficient of 1.38 [7], 
MBOCA might be concentrated in lipid-rich tissues. Alternatively, since carcinogens 
Abbreviation: MBOCA, 4.4’.methylene bis(2-chloranihne); MFO, mixed-function oxidase. 
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such as MBOCA are metabolized and, therefore, activated by N-hydroxylation 
followed by esterification [7], MBOCA might concentrate into tissues rich in MFO. 
To assess the body burden of MBOCA and its relationship to the observed 
neoplasms, we report the kinetics of tissue distribution and elimination of 
[i4C]MBOCA in the rat. 
MATERIALS AND METHODS 
Formulation of [14C]A4BOCA 
[14C]MBOCA was obtained from the Amersham Corp. with a spec. act. of 58 
mCi/mmol (216 &i/mg). Radiochemical purity was >98% as determined by thin- 
layer chromatography on silica gel in benzene-acetone (4: 1) and cyclohexane-ether 
(1:l). [14C]MBOCA was formulated in a mixture of 100% ethanol-Tween-80 
redistilled and deionized water (49.6: 12.9:37.5). 
Animals 
Female Sprague-Dawley rats, obtained from Charles River Breeding 
Laboratories, Portage, MI, were used in all studies. During all studies, the rats were 
maintained on feed (Purina Rat Chow) and water ad lib and on a 12:12 light-dark 
schedule until killing. Rats were individually placed into metabolic cages for the 
elimination studies. 
Tissue distribution studies 
Rats, 235 + 34 g body weight, were lightly anesthetized with ether and dosed i.v. 
with 0.49 mg/kg (106.4 &i/kg) of [‘4C]MBOCA. After 0.17 (10 min), 1.0,4.0, and 
16.0 h, the rats were, again, lightly anesthetized and killed by decapitation. 5 or 6 
rats were evaluated at each time point. Duplicate samples of up to 20 different 
tissues from each rat were weighed, oxidized in a Packard Model 306 sample ox- 
idizer, and counted in a Packard Model 3330 liquid scintillation counter with correc- 
tions made for background and counter efficiency. Blood samples were obtained by 
cardiac puncture just prior to decapitation. Skin samples were obtained from the 
same site distant from the injection site. Brain white matter samples were obtained 
from the optic nerve and corpus collosum, and brain grey matter samples were ob- 
tained from the anterior cerebral cortex. To normalize the differences in animal 
weights, tissue concentrations are expressed as % kg dose/g [8]. The results are 
reported as mean ? S.E.M. 
Subcellular distribution studies 
4 rats, 312 * 29 g body weight, were lightly anesthetized with ether and dosed 
i.v. with 0.37 mg/kg (80.1 &i/kg) of [14C]MBOCA. They were anesthetized and 
killed by decapitation at 1 .O h. Samples, 1 .O g, of each liver were removed, weighed, 
homogenized in 0.25 M sucrose, and fractionated [9]. Each fraction was analyzed 
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for radioactivity by oxidizing and counting as previously described. The distribution 
is expressed in %, based on the relative radioactivity recovered in each of the four 
fractions. The overall recovery of the total radioactivity in the four fractions was 
97.74 + 5.62% of the total radioactivity in the intact liver. The results are reported 
as mean f S.D. 
Urinary and fecal elimination studies 
4 rats, 229 f 13 g body weight, received mild anesthesia with ether and were dos- 
ed i.v. with 0.51 mg/kg (109.2 &i/kg) of [14C]MBOCA. Urine and feces were col- 
lected at 12, 24, and 48 h. The samples were weighed, oxidized and counted as 
previously described. The elimination is expressed in cumulative %, mean f SD., 
of the administered dose. 
RESULTS AND DISCUSSION 
As a preliminary assessment of the body burden of MBOCA and its relationship 
to the sites of the observed neoplasms, we studied the tissue distribution kinetics of 
[14C]MBOCA after a single dose (0.49 mg/kg body weight, i.v.) as shown in Table 
I. [r4C]MBOCA was found in highest concentrations in the small intestine, liver, 
adipose, lung, kidney, skin, and adrenals, however [14C]MBOCA was distributed 
throughout the body. [‘4C]MBOCA was also detected in the brain with approx. a 
1.7-fold greater concentration in white matter as compared to grey matter. 
[14C]MBOCA was rapidly distributed throughout the body, as demonstrated by the 
organ distribution at 0.17 h (10 min). A rapid removal of the radioactivity followed 
by a slower rate of removal was observed for most tissues. The blood clearance of 
the injected radioactivity demonstrated similar kinetics. However, small intestine, 
adipose, and skin demonstrated a short period of increasing radioactivity in contrast 
to the quick decline in radioactivity observed in all other tissues. 
Since the liver contained the greatest concentration of [14C]MBOCA at 0.17 h (10 
min), approx. 19% of the administered dose, and retained much of the radioactivity 
over time, we studied the subcellular distribution of the radioactivity at 1 h as a 
preliminary assessment of the role of metabolism on the deposition of 
[14C]MBOCA. As shown in Table II, radioactivity was found in all cell fractions. 
MBOCA has been suggested to be metabolized by cytochrome P-450-dependent 
hydroxylation and various esterases. Cytochrome P-450 has been detected in various 
organs with high levels in the adrenal cortex, liver, kidney, lung and ovaries [lo-121. 
[14C]MBOCA was found to concentrate into these tissues rich in MFO. The sustain- 
ed retention of the radioactivity in the liver might be due to the formation of a 
covalent complex with cytochrome P-450 of specific MFO, as has been 
demonstrated for 1 , 1,l -trichloro-2,2-bis @-chlorophenol) ethane [ 131. 
The concentration of [14C]MBOCA into the small intestine, adipose, and skin 
suggests that other dynamics are involved. The transient increase of radioactivity in 
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TABLE I 
TIME-DEPENDENT TISSUE DISTRIBUTION OF [%]MBOCA IN RATS 
Tissue Tissue Concentration, % kg dose/g (Mean f S.E.M.) 
0.17 h 1.0 h 4.0 h 16.0 h 























0.0644 + 0.0045 0.1826 ?z 0.0364 
0.3846 + 0.0121 0.1136 + 0.0141 
0.0656 + 0.0094 0.0198 + 0.0040 
0.0698 k 0.0041 
0.2254 + 0.0746 
0.1847 + 0.0053 
0.4964 * 0.0099 
0.2490 + 0.0149 
- 
0.1940 t 0.0120 
0.2036 f 0.0102 
0.0800 + 0.0127 
0.0871 + 0.0103 
0.1576 f 0.0099 
- 
- 
0.0903 + 0.0063 
0.0281 * 0.0023 
0.0485 + 0.0216 
0.0427 k 0.0022 
0.0594 f 0.0270 
0.2635 + 0.0755 
0.1346 f 0.0091 
0.2458 + 0.0080 
0.1702 + 0.0106 
0.0318 + 0.0036 
0.0489 f 0.0061 
0.0514 f. 0.0035 
0.1264 + 0.0404 
0.0328 + 0.0018 
0.0466 rt 0.0053 
0.0380 + 0.0050 
0.0307 -I- 0.0022 
0.0333 + 0.0013 
0.1449 + 0.0061 
0.0067 + 0.0027 




0.0115 * 0.0004 
0.2996 f 0.1027 
0.0918 + 0.0045 
0.1694 f 0.0104 
0.1257 + 0.0115 
- 
0.0395 -I 0.0005 
- 
0.0375 + 0.0026 
0.0408 k 0.0141 
- 
- 
0.0270 k 0.0014 
0.0411 * 0.0047 
0.0406 * 0.0028 
0.0052 f 0.0004 
_ 
_ 
0.0103 + 0.0007 
0.0163 + 0.0020 
0.0607 + 0.0044 
0.1068 + 0.0102 
0.0737 k 0.0060 
_ 
0.0264 + 0.0032 
_ 
0.0058 + 0.0006 
0.0160 + 0.0052 
_ 
0.0100 & 0.0005 
TABLE II 
SUBCELLULAR DISTRIBUTION OF [%]MBOCA IN RAT LIVER AT 1 .O h 
Fraction ( x g) % 
Distributiona 
O-500 28.72 -t 2.07 
500- 12,000 19.65 + 0.27 
12000-100000 20.08 * 1.14 
> 100000 31.56 + 2.29 
aEach value is based on the relative radioactivity recovered in each of the four fractions and expressed 
as the mean f S.D. of the value for that fraction from 4 rats. 
skin and adipose, accompanying the rapid removal of radioactivity from other 
tissues, may result from a shift of the biodistribution to those sites of higher lipid 
content. The lipophilicity of MBOCA might also explain the greater concentration 
into brain white matter as compared to grey matter and the detection of radioactivi- 
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Fig. 1. Cumulative elimination kinetics of [%]MBOCA from rats via (A) feces and (B) urine. The mean 
2 S.D. is plotted for each time point. 
ty in all membrane-containing fractions of the liver. The transient increase and high 
uptake into the smaIl intestine suggest that other dynamics are involved such as the 
re-absorption of [r4C]MBOCA metabolites as they pass through the small intestine. 
The elimination kinetics of [r4C]MBOCA was also studied to assess the body 
burden of MBOCA. As shown in Fig. 1 [‘4C]MBOCA was rapidly eliminated from 
the body with the total cumulative urinary and fecal elimination of 35.4, 79.4, and 
94.6% at 12, 24, and 48 h, respectively. The major route of elimination was via the 
feces, which represented 73.4% of the total cumulative 070 dose at 48 h. 
These kinetic studies in the rat indicate whole body uptake occurs within minutes 
and elimination occurs within 48 h after a single i.v. dose. The major route of detox- 
ification and elimination appears to be metabolism by the liver, movement through 
the intestinal tract, and removal via the feces. The observed kinetics of tissue up- 
take, distribution, and elimination may, however, be dependent on the route of ex- 
posure as well as the species studied. There are known species differences in MFO 
distribution [14]. Skin absorption is a major route of human exposure [15]. 
Preliminary reports suggest, however, that the elimination kinetics of [14C]MBOCA 
was not affected by dose or route of administration in rat, dog, or man [16, 171. 
A preliminary report on the distribution of the radioactivity at 48 h after a single 
i-p. or p.o. dose of [*4C]MBOCA into 2 rats for each route demonstrated concentra- 
tion of the radioactivity into the liver and adipose tissue [16]. These observations 
suggest that the route of administration does not affect the tissue distribution. 
Although we have observed concentration of [r4C]MBOCA into those tissues 
where metabolism of MBOCA might occur and where subsequent neoplasms have 
been observed, we do not know the activated metabolite involved and the tissue dose 
required to achieve carcinogenesis [ 181. Multiple exposures to MBOCA might 
demonstrate greater and more persistent concentrations of MBOCA in the liver, the 
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major site of neoplasms. Our studies indicate that a single exposure at a subphar- 
macologic dose in the rat is rapidly distributed and eliminated. Further studies will 
be needed to fully understand the body burden of MBOCA and its relationship to 
carcinogenesis. 
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